Navigation Links
Strategic Diagnostics Launches Initial Oncology-Targeted Antibody Reagent Catalog
Date:10/2/2007

ity when compared to reagents produced through traditional methods.

The SEQer catalog of antibodies addresses a number of well-known challenges associated with currently available reagents. Specifically, deficiencies in the ability to replicate the three dimensional conformation of target proteins through synthetic immunogens have resulted in reagents that do not reliably recognize or differentiate their intended targets. This, in turn, limits reagent performance and creates a level of uncertainty regarding the data produced with traditionally produced reagents. The SEQer antibody is focused on addressing the loss of productivity in research and development endeavors.

"The performance of our SEQer antibodies has been demonstrated with our many private and public collaborators in numerous assays," Mr. Knight said. "The programs have included significantly large screens for oncology markers and the ability to stain disease-associated proteins across thousands of clinical biopsy samples. More targeted studies have shown the ability to differentiate highly conserved proteins in cell sorting assays, the ability to react with traditionally elusive proteins of interest, and be directed through SDI's design algorithms to target functional sites in monoclonal applications."

SDI's GAT-produced antibodies are significantly better than traditional protein/peptide-produced antibodies, as they are produced in vivo by the host animal's natural immune system, and are therefore able to behave both chemically and mechanically as any naturally produced antibody would.

Oncology Focus

The SEQer oncology-focused portfolio is comprised of antibody tools that target proteins associated with cancer pathogenesis and progression, thereby succeeding in delivering usable data for more proteins and in more applications. SDI strategically focused on the area of oncology, as more than half of NIH-funded research and the majority of proteomic efforts are currently focu
'/>"/>

SOURCE Strategic Diagnostics Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Answerthink and LORENZ Life Sciences Group Announce Strategic Alliance for the SAP Life Science Industry
2. New Advances in Gastric Diagnostics: Smaller is Better
3. West Nile Virus Screening and Diagnostics Technology Emerges In Step with North American Outbreak
4. An Investigational Study Released at ADA Showed that Initial Combination Therapy with Januvia (sitagliptin) and Metformin Led to Improvement in Markers of Beta Cell Function in Patients with Type 2 Diabetes
5. Tranzyme Pharma Presents Initial Phase IIa Data for its Novel Ghrelin Agonist, TZP-101, in Patients with Diabetic Gastroparesis
6. Late Breaking Data Released at ADA Showed that the Investigational Use of Januvia and Metformin as Initial Combination Therapy Provided Significant Glucose Lowering Efficacy over 54 Weeks in Patients with Type 2 Diabetes
7. Immunomedics Reports Initial Clinical Results With Hpam4 For Pancreatic Cancer Therapy
8. Pharmacopeia Announces Positive Results from Initial DARA Clinical Trial
9. Phase I Results for ImClone Pipeline Anti-IGF-1R Monoclonal Antibody IMC-A12 Presented at ASCO
10. Vicals Vaxfectin Adjuvant With Needle-free Delivery Enhances DNA Vaccine Performance; Yields Antibody Responses Comparable to Electroporation Without Tolerability Issues
11. Positive Results Using Affitech-Identified Human Antibody That Blocks VEGF Binding to VEGF Receptor 2 in Preclinical Cancer Model Reported by Peregrine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... RnRMarketResearch.com adds "Pemphigus - ... of 68 pages with latest updates, data and ... The report "Pemphigus - Pipeline Review, H1 2015" report ... for Pemphigus , complete with comparative analysis at ... of action (MoA), route of administration (RoA) and ...
(Date:3/31/2015)... KENNEBUNK, Maine , March 31, 2015 /PRNewswire/ ... aggregated enrollment in Medicare Advantage (MA) plans in ... approximately 17.3 million people were enrolled in Medicare ... of more than 1.3 million members year-over-year.  54.3 ... the Centers for Medicare and Medicaid Services (CMS), ...
(Date:3/31/2015)...  SynCardia Systems, Inc. has received FDA approval to ... the effective use of its 50cc SynCardia temporary Total ... The FDA approval will allow SynCardia to launch ... patients. Patients enrolled in this study will receive the ... a donor heart transplant. (Caution-In the United States, ...
Breaking Medicine Technology:Pemphigus Therapeutic Development and Pipeline Review H1 2015 2Pemphigus Therapeutic Development and Pipeline Review H1 2015 3Pemphigus Therapeutic Development and Pipeline Review H1 2015 4Medicare Advantage Enrollment Reaches 17 Million According to Mark Farrah Associates 2FDA Approves Investigational Study for New Smaller SynCardia Total Artificial Heart 2FDA Approves Investigational Study for New Smaller SynCardia Total Artificial Heart 3FDA Approves Investigational Study for New Smaller SynCardia Total Artificial Heart 4
... 2011 Reportlinker.com announces that a new market ... Hospital Angiography Census ... most comprehensive European market report on the installed ... R&F, Angiography, CT, MRI,) and radiology IT systems ...
... China, Jan. 20, 2011 /PRNewswire-Asia/ -- Winner Medical ... Medical") a leading manufacturer of medical dressings, medical ... PurCotton® products in China, today announced that one ... ("Huanggang Cotton"), was recently awarded a Cotton Processing ...
Cached Medicine Technology:Reportlinker Adds Hospital Angiography Census 2Reportlinker Adds Hospital Angiography Census 3Winner Medical Obtains Cotton Processing Certificate from the State Development and Reform Commission 2Winner Medical Obtains Cotton Processing Certificate from the State Development and Reform Commission 3
(Date:3/31/2015)... Researchers at UC Davis have ... how human livers heal. The difference centers on ... Normally, mouse PPARa is far more active and ... quickly regenerate damaged livers. However, the research shows ... boost the regenerative effects of human PPARa. The ...
(Date:3/31/2015)... Mission, TX (PRWEB) March 31, 2015 One of ... would be a visit to Mount Kilauea on the big island. ... the few places where you can see molten lava slowly oozing ... spectacles on earth. , One place you would never ... in the flat, arid terrain of Mission, Texas -- until now. ...
(Date:3/31/2015)... 31, 2015 Indosoft, Inc., developers of ... the availability of SIP over TCP configuration for all SIP ... offering a full contact center ACD (Automatic Call ... Adding SIP over TCP support to all SIP devices gives ... The history of Voice over IP (VoIP) has primarily involved ...
(Date:3/31/2015)... (PRWEB) March 31, 2015 National ... physical, social and psychological benefits of participating in ... thousands of adaptive sports athletes that adapt, believe ... encourage support for inclusive fitness and inclusive athletics ... in participating in adaptive sports and advocate for ...
(Date:3/31/2015)... March 31, 2015 Array Health ... technology, has announced that Lance Hood, Senior Director of ... Private Exchange Forum on April 1, 2015. The session, ... Benaissance, will address how employers can streamline and simplify ... , WHAT: “ Optimizing Employee and Employer Needs in ...
Breaking Medicine News(10 mins):Health News:UC Davis Study Finds Protein May Improve Liver Regeneration 2Health News:UC Davis Study Finds Protein May Improve Liver Regeneration 3Health News:UC Davis Study Finds Protein May Improve Liver Regeneration 4Health News:Rare Volcano Constructed inside Gold’s Gym in Mission, Texas 2Health News:Rare Volcano Constructed inside Gold’s Gym in Mission, Texas 3Health News:Indosoft extends SIP over TCP support to User Extensions in its Q-Suite 5.9 Call Center Software 2Health News:April is National Adaptive Sports Month 2Health News:April is National Adaptive Sports Month 3Health News:Array Health’s Senior Director of Marketing to Co-Present with Benaissance at The Institute for HealthCare Consumerism Private Exchange Forum 2
... 2009 ,Potential Benefits of Intermittent Androgen Suppression Therapy ... of the Literature, is the title of an article ... European Urology , the official journal of the European ... the efficacy and tolerability of intermittent androgen deprivation (IAD) ...
... team made up of mental health professionals, emergency response ... has published the results of a study that shows ... Hurricane Katrina. The Category 3 storm ravaged the Gulf ... a recent issue of the Journal of the ...
... a multi-bed hospital room dramatically increases the risk of acquiring ... A new study led by infectious diseases expert Dr. Dick ... C. difficile ( Clostridium difficile ) rises with ... in a two, three or four-bedded room, each time you ...
... ,A new study shows that poor lung function ... factors, including birth weight, height, and gender. Researchers from Newcastle ... patients, all aged 14 years. Follow-up data also were obtained ... Results showed that several factors were related to poorer lung ...
... from the Society of Breast Imaging (SBI) and the ... published in the January issue of the Journal ... that breast cancer screening should begin at age 40 ... appropriate utilization of medical imaging modalities such as mammography, ...
... to sexual arousal, whereas in men, the responses of ... each other, according to Assistant Professor Meredith Chivers, from ... Michael Seto, Martin Lalumire, Ellen Laan, and Teresa Grimbos. ... ratings and physiological measures of sexual arousal in men ...
Cached Medicine News:Health News:Intermittent androgen deprivation at least as effective as continuous androgen deprivation 2Health News:Sharing a hospital room increases risk of 'super bugs' 2Health News:News briefs from the January issue of Chest 2Health News:New SBI and ACR recommendations suggest breast cancer screening should begin at age 40 2Health News:Women's bodies and minds agree less than men's on what's sexy 2
... for the mid- to high-volume lab, the ... can reduce time-consuming manual tasks by as ... performs random access, STAT, HCFA panels and ... including Stat chemistries, General chemistries, TDMs, DATs, ...
... on-board capacity of 57 assays ... 146 tests, the CX1000 PRO ... so you can maximize your ... workload. The CX1000 PRO creates ...
When it comes to providing speed, accuracy and menu flexibility, the SYNCHRON CX5 PRO has it all. The state-of-the-art CX5 PRO starts with the wide SYNCHRON chemistry menu to create the ideal full-se...
The leading fully automated system for plasma protein determinations. Third generation nephelometer combines reliability with highly cost-effective performance....
Medicine Products: